Google

Influenza A H1N1 influenza epidemic on a global scale showed rapid upward trend in
1. The current global and China's Influenza H1N1 flu situation?
At present, the influenza A H1N1 influenza outbreak that is spreading worldwide. With the advent of autumn and winter in the northern hemisphere, North America, Europe, Asia and other regions of the influenza A H1N1 influenza epidemic continues to spread rapidly worldwide have accumulated more than 5,000 deaths reported. World Health Organization, the actual incidence and deaths in the world far exceeds the number of reports.
As of October 31, China's mainland had reported confirmed cases of Influenza A H1N1 influenza 4.6 thousand cases, of which more than 90 cases of severe cases and deaths occurred. At present, many local cases of influenza-like surge, many clusters of cases in schools, in some areas has entered the influenza peak season. Monitoring indicates that the virus has not mutated, but nearly 80% of influenza cases for the Influenza A H1N1 influenza patients. The coming period, the epidemic will continue to develop prevention and control of the situation will be even more severe.
2. Why should the people of China H1N1 influenza vaccine Influenza vaccination?
H1N1 influenza vaccine is to prevent an effective means of an influenza pandemic. Influenza A H1N1 vaccine immunization can stimulate the body to produce against the influenza A H1N1 influenza virus antibodies, the virus caused by influenza immunization can play a preventive role.
3. China's R & D Influenza H1N1 influenza vaccine is safe and effective?
Clinical trial results and vaccination work practices have proved that China-made influenza A H1N1 influenza vaccine is safe and effective.
10 domestic vaccine production enterprises in the seven provinces in the implementation of the world's largest vaccine clinical trials, 10003 thousand people had received clinical trials. The results showed that: inoculation a second 15μg cracking Influenza H1N1 influenza vaccines can result in effective protection, protection rate of more than 85%; is particularly important is that a good vaccine safety, adverse reaction rates of no more than seasonal influenza vaccine, No serious side effects. Some other countries, international clinical trial results also support the conclusions of clinical trials in China. Early in September, after the State Food and Drug Administration approval, Influenza H1N1 influenza vaccine officially put into production, China has become the world's first complete vaccine development and registration of the use of state. Vaccine research and development of China's achievements have been highly affirmed by the World Health Organization.

http://c707dhwtoxm43vc5fzlo8z3ye6.hop.clickbank.net/
http://5b0658spo7pahumrvn338cjk9l.hop.clickbank.net/